There are 2789 resources available
105P - Prognostic value of the NTRK fusion biomarker in the Netherlands
Presenter: Irene Santi
Session: ePoster Display
106P - Prognostic impact of memory CD8(+) T cells on immunotherapy in human cancers: A systematic review and meta-analysis
Presenter: Yao Jin
Session: ePoster Display
205P - Immunomodulation in early triple-negative breast cancer (TNBC): Analysis of soluble markers as predictive biomarkers to neoadjuvant chemotherapy in TNBC
Presenter: Martin Nunez Abad
Session: ePoster Display
206P - Disease behavior and treatment response of special histological types of triple-negative breast cancer
Presenter: Renata Bonadio
Session: ePoster Display
207P - Outcomes of patients with triple-negative breast cancer following neoadjuvant chemotherapy with anthracycline and taxane-based regimens plus carboplatin
Presenter: Bryan Vaca Cartagena
Session: ePoster Display
208P - ARB: Phase II window of opportunity study of preoperative treatment with enzalutamide in ER+ve and TNBC
Presenter: Peter Schmid
Session: ePoster Display
209P - Interim results of a phase I/Ib study of SBT6050 monotherapy and pembrolizumab combination in patients with advanced HER2-expressing or amplified solid tumors
Presenter: Samuel Klempner
Session: ePoster Display
210P - TACH101, a first-in-class KDM4 inhibitor for treatment of triple-negative breast cancer
Presenter: Frank Perabo
Session: ePoster Display
307P - Overall survival in metastatic breast cancer patients according to different follow up strategies for early breast cancer
Presenter: Eva Blondeaux
Session: ePoster Display
308P - FDG-PET/CT versus CE-CT for response monitoring in metastatic breast cancer: A prospective comparative study
Presenter: Marianne Vogsen
Session: ePoster Display